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scherichia coli is both the most abundant facultative
commensal of the human gastrointestinal tract and the
most common bacterial cause of human diarrhea (1).
However, precise recognition of E. coli pathotypes
remains problematic. Enteropathogenic E. coli (EPEC),
classically associated with outbreaks of infant diarrhea,
harbors distinctive chromosomal (the locus of enterocyte
effacement, or LEE island) and plasmidborne (residing on
the EPEC adherence factor, or EAF, plasmid) virulence
factors, which are linked by common gene regulators (1).
At the Second International Conference on EPEC, held in
São Paulo, Brazil, in 1995, the foremost authorities in the
field proclaimed the global importance of such “typical”
EPEC (tEPEC) but pondered the clinical relevance of
strains carrying only the LEE island (dubbed at that con-
ference “atypical EPEC,” or aEPEC) (2). Had aEPEC lost
the EAF plasmid? Had it incidentally acquired only frag-
ments or incomplete packages of virulence-associated
genes? Or were some aEPEC true pathogens of humans or
animals? 
In this issue of Emerging Infectious Diseases, Nguyen
et al. propose a distinct role for aEPEC in human infection
(3). Previously, these investigators reported a high preva-
lence of aEPEC among pediatric diarrhea patients in
Melbourne, including both infants and older children (in
contrast to the strong tendency for infants to be infected
with tEPEC) (4). Now these authors show that, in contrast
to patients infected with other pathogens, patients infected
with aEPEC are far more likely to experience diarrhea past
14 days, the point long recognized as a clinical watershed
that heralds increased risk for illness and death. aEPEC’s
prevalence among diarrhea patients, the pathogen’s strong
association with diarrheal symptoms, and the infection’s
distinctively persistent nature argue for a high disease bur-
den in Melbourne. Although the authors define aEPEC
strictly on the basis of positivity for the LEE eae gene and
failure to amplify a bfpA pilin gene (not assessing addition-
al plasmid loci), the absence of tEPEC serotypes and the
occurrence of disease in children older than infants suggest
that these are indeed aEPEC. 
This communication also illustrates 2 principles that
should be recognized more generally with regard to diar-
rheogenic E. coli: 1) one can authoritatively implicate a
particular strain as a pathogen by (only) outbreak implica-
tion or by volunteer studies, but one cannot definitively
prove by any data that a putative pathotype is not a human
pathogen; and 2) the implication of pathogenicity for 1
strain is not sufficient to implicate any similar strain as a
pathogen. Thus, once definitive evidence is presented that
a particular strain is pathogenic, the challenge is to deter-
mine the genotypic or phenotypic fingerprints that permit
extrapolation to other strains. This obstacle has long
proved daunting for the enteroaggregative pathotype
(shown to be pathogenic in both volunteer studies and out-
breaks), and it may prove similarly frustrating for aEPEC. 
Diarrheal epidemiology studies today are able to identi-
fy a likely etiologic agent for most patients, in contrast to
studies of 20 years ago, because of improved diagnostic
tests and the identification of new pathogens, but the task is
not finished. Additional studies are needed in many places
to refine our understanding of putative and emerging
pathogens and to determine their full epidemiologic roles.  
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